The Peptide AppThe Peptide App

The Peptide AppField Guide · Metabolic SeriesField Specimen

Metabolic Category

Tesofensine

THE APPETITE CRUSHER

TE-1; NS2330

Tesofensine is a triple monoamine reuptake inhibitor that was originally developed for Parkinson's and Alzheimer's. It blocks reuptake of dopamine, norepinephrine, and serotonin, powerfully reducing appetite and increasing energy expenditure. In trials it produced greater weight loss than any other single agent, making it one of the most effective compounds for obesity.

Tesofensine
Tesofensine
Tesofensine

Tesofensine Evidence Snapshot

How these guides are reviewed
Regulatory status
Not FDA approved · research use only
Dosing guidance
Reviewed by our clinical team
Linked evidence
1 research sources
Content updated
Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Tesofensine

Is Tesofensine FDA approved?

No. This profile records Tesofensine as not FDA approved and for research use only.

More context

Review the regulatory and source details on this page for the current context.

What dose does The Peptide App Clinical Team recommend for Tesofensine?

Dose: 0.25-0.5 mg orally once daily.

More context

Schedule: daily. Cycle: Ongoing with medical supervision. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

What research supports this Tesofensine guide?

This guide links to 1 curated or current research sources.

More context

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Review the Tesofensine research sources

Studied Effects & Mechanisms

Triple Reuptake Inhibition

Blocks DAT, NET, and SERT transporters

Appetite Suppression

Increases monoamines in hypothalamic feeding centers

Thermogenesis

Enhances sympathetic activity and energy expenditure

Cognitive Enhancement

Improves dopamine-mediated focus and motivation

Who is this for

Those with significant weight to lose
People who struggle with appetite control
Those who haven't responded to other weight loss drugs
Anyone wanting cognitive boost alongside weight loss

Research-Market Price Snapshot

A compact market signal for this profile. The dedicated pricing page owns vendor, vial-size, and price-per-mg comparisons.

Live pricing

The live pricing feed did not return ready in-stock rows for this peptide.

Open the dedicated pricing page →

Market evidence

Tesofensine product testing and COAs

Current certificates are on file for 9 of 25 vendors tracked in the Tesofensine market. Research on this page describes the molecule. Vendor certificates concern particular market samples or batches; they do not change the research evidence or establish clinical safety, sterility, or suitability for use.

Tesofensine Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.

Related Peptides

Retatrutide

THE GAME CHANGER
CModerate
Weight Management · Appetite & Metabolic ControlMetabolic · Weight ManagementDose1 mgCycle12 weeks on, 12 weeks off (per clinical trials)Kicks inWeight loss typically begins within the...

Triple-action peptide with 24% average weight loss in trials.

from $3.26/mg · 160 vendorsNº 003 / 006

Tirzepatide

THE TRANSFORMER
AHigh
Metabolic Modulator · Weight ManagementMetabolic · Metabolic ModulatorDose2.5 mgCycle12-24 weeks per treatment cycleKicks inAppetite reduction within first week....

FDA-approved for weight loss. Patients lose 20%+ of their body weight.

from $1.75/mg · 109 vendorsNº 006 / 006

Mazdutide

THE DUAL ACTIVATOR
CModerate
Appetite & Metabolic Control · Weight ManagementMetabolic · Appetite & Metabolic ControlDose1 mgCycleOngoing as prescribed in clinical trialsKicks inWeight loss typically begins in the first...

Next-gen weight loss with dual hormone action

from $4.49/mg · 15 vendorsNº 002 / 006

Semaglutide

THE APPETITE CONTROLLER
BGood
Metabolic Modulator · Weight ManagementMetabolic · Metabolic ModulatorDose250 mcgCycleOngoing as prescribedKicks inWeight loss typically begins within 2-4...

FDA-approved GLP-1 that produced 15% weight loss in trials.

from $0.12/mg · 74 vendorsNº 004 / 006

Setmelanotide

THE GENETIC HUNGER CONTROLLER
BGood
Weight Management · Appetite & Metabolic ControlMetabolic · Weight ManagementDoseSee guideCycleOngoing as prescribedKicks inWeight loss typically begins within the...

FDA-approved for rare genetic obesity disorders

from $6/mg · 1 vendorNº 005 / 006

5-Amino-1MQ

THE FAT BURNER
BGood
Metabolic Modulator · Weight ManagementMetabolic · Metabolic ModulatorDose150 mcgCycle3 weeks on, 1 week offKicks inMost users notice energy improvements within...

Boost metabolism and burn fat without changing your diet

from $0.68/mg · 96 vendorsNº 001 / 006